WVE Dividend: WAVE Life Sciences Ltd Yield Insights

WVE Financial

WAVE Life Sciences Ltd

$7.62

6.72%

$0.48

At close: Dec 04, 16:00:00 GMT-5

$7.67

0.65%

$0.04

Post-market: Dec 04, 18:27:16 GMT-5

Income

Balance sheet

Cash flow

Annual

Quarterly

WVE Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	109	108	113	3	40	20
Revenue Growth (YoY)	106%	-4%	3,667%	-93%	100%	33%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	70	59	51	50	46	42
Research & Development	174	159	130	115	121	130
Operating Expenses	245	218	181	166	167	173
Other Non Operating Income (Expenses)	2	3	1	0	4	2
Pretax Income	-122	-97	-58	-161	-122	-150
Income Tax Expense	0	0	0	0	0	0
Net Income	-122	-97	-57	-161	-122	-149
Net Income Growth	-14%	70%	-65%	32%	-18%	-23%
Shares Outstanding (Diluted)	167.73	138.27	106.09	78.86	51.83	39.23
Shares Change (YoY)	26%	30%	35%	52%	32%	16%
EPS (Diluted)	-0.73	-0.7	-0.54	-2.05	-2.36	-3.82
EPS Growth	-31%	28.99%	-74%	-13%	-38%	-33%
Free Cash Flow	-198	-151	-20	-129	-89	-117
Free Cash Flow Per Share	-1.18	-1.09	-0.18	-1.63	-1.71	-2.98
Gross Margin	--	--	--	--	--	--
Operating Margin	-123.85%	-101.85%	-59.29%	-5,400%	-317.5%	-765%
Profit Margin	-111.92%	-89.81%	-50.44%	-5,366.66%	-305%	-745%
Free Cash Flow Margin	-181.65%	-139.81%	-17.69%	-4,300%	-222.5%	-585%
EBITDA	-132	-107	-62	-156	-120	-145
EBITDA Margin	-121.1%	-99.07%	-54.86%	-5,200%	-300%	-725%
D&A For EBITDA	3	3	5	6	7	8
EBIT	-135	-110	-67	-162	-127	-153
EBIT Margin	-123.85%	-101.85%	-59.29%	-5,400%	-317.5%	-765%
Effective Tax Rate	0%	0%	0%	0%	0%	0%